Literature DB >> 16919608

Effects of apoE isoforms on beta-amyloid-induced matrix metalloproteinase-9 in rat astrocytes.

Shuzhen Guo1, Sophia Wang, Woo Jean Kim, Sun-Ryung Lee, Matthew P Frosch, Brian J Bacskai, Steven M Greenberg, Eng H Lo.   

Abstract

Matrix metalloproteinase-9 (MMP-9) may play a role in the inflammatory glial response during Alzheimer's disease (AD). Astrocytes can degrade beta-amyloid (Abeta) and extracellular proteolysis via MMP-9 may be involved. Because Apolipoprotein E (APOE) genotype is an important factor for AD, we ask whether various apoE isoforms can influence Abeta-induced MMP-9 responses in primary rat astrocytes. Our data show that apoE4 significantly dampens Abeta-induced MMP-9 levels, possibly by downregulating the Rho-Rho kinase (ROCK) pathway. Reduction of astrocytic MMP-9 by apoE4 may affect Abeta clearance and promote Abeta deposition in AD.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16919608     DOI: 10.1016/j.brainres.2006.06.041

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  12 in total

Review 1.  Neurovascular matrix metalloproteinases and the blood-brain barrier.

Authors:  Ji Hae Seo; Shuzhen Guo; Josephine Lok; Deepti Navaratna; Michael J Whalen; Kyu-Won Kim; Eng H Lo
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

Review 2.  Cytochrome P450 derived epoxidized fatty acids as a therapeutic tool against neuroinflammatory diseases.

Authors:  Jogen Atone; Karen Wagner; Kenji Hashimoto; Bruce D Hammock
Journal:  Prostaglandins Other Lipid Mediat       Date:  2019-11-05       Impact factor: 3.072

3.  Role of matrix metalloproteinase 3-mediated alpha-synuclein cleavage in dopaminergic cell death.

Authors:  Dong-Hee Choi; Youn-Jung Kim; Young-Gun Kim; Tong H Joh; M Flint Beal; Yoon-Seong Kim
Journal:  J Biol Chem       Date:  2011-02-17       Impact factor: 5.157

4.  Matrix metalloproteinase inhibition reduces oxidative stress associated with cerebral amyloid angiopathy in vivo in transgenic mice.

Authors:  Monica Garcia-Alloza; Claudia Prada; Carli Lattarulo; Sara Fine; Laura A Borrelli; Rebecca Betensky; Steven M Greenberg; Matthew P Frosch; Brian J Bacskai
Journal:  J Neurochem       Date:  2009-04-08       Impact factor: 5.372

5.  Matrix metalloproteinase 9-mediated intracerebral hemorrhage induced by cerebral amyloid angiopathy.

Authors:  Lingzhi Zhao; Michal Arbel-Ornath; Xueying Wang; Rebecca A Betensky; Steven M Greenberg; Matthew P Frosch; Brian J Bacskai
Journal:  Neurobiol Aging       Date:  2015-07-16       Impact factor: 4.673

Review 6.  Cerebral amyloid angiopathy and Alzheimer disease - one peptide, two pathways.

Authors:  Steven M Greenberg; Brian J Bacskai; Mar Hernandez-Guillamon; Jeremy Pruzin; Reisa Sperling; Susanne J van Veluw
Journal:  Nat Rev Neurol       Date:  2019-12-11       Impact factor: 42.937

7.  Amyloid β Oligomers Disrupt Blood-CSF Barrier Integrity by Activating Matrix Metalloproteinases.

Authors:  Marjana Brkic; Sriram Balusu; Elien Van Wonterghem; Nina Gorlé; Iryna Benilova; Anna Kremer; Inge Van Hove; Lieve Moons; Bart De Strooper; Selma Kanazir; Claude Libert; Roosmarijn E Vandenbroucke
Journal:  J Neurosci       Date:  2015-09-16       Impact factor: 6.167

Review 8.  Neuroprotective and neurotoxic properties of glial cells in the pathogenesis of Alzheimer's disease.

Authors:  D Farfara; V Lifshitz; D Frenkel
Journal:  J Cell Mol Med       Date:  2008-03-20       Impact factor: 5.310

9.  Matrix metalloproteinase-3 causes dopaminergic neuronal death through Nox1-regenerated oxidative stress.

Authors:  Dong-Hee Choi; Ji-Hye Kim; Joo-Ha Seo; Jongmin Lee; Wahn Soo Choi; Yoon-Seong Kim
Journal:  PLoS One       Date:  2014-12-23       Impact factor: 3.240

Review 10.  Matrix metalloproteinases and their multiple roles in Alzheimer's disease.

Authors:  Xiang-Xiang Wang; Meng-Shan Tan; Jin-Tai Yu; Lan Tan
Journal:  Biomed Res Int       Date:  2014-06-24       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.